Mainga Hamaluba

8.2k total citations
20 papers, 389 citations indexed

About

Mainga Hamaluba is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Infectious Diseases. According to data from OpenAlex, Mainga Hamaluba has authored 20 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 7 papers in Public Health, Environmental and Occupational Health and 5 papers in Infectious Diseases. Recurrent topics in Mainga Hamaluba's work include Pneumonia and Respiratory Infections (5 papers), Bacterial Infections and Vaccines (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Mainga Hamaluba is often cited by papers focused on Pneumonia and Respiratory Infections (5 papers), Bacterial Infections and Vaccines (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Mainga Hamaluba collaborates with scholars based in United Kingdom, Kenya and United States. Mainga Hamaluba's co-authors include Mohan Shenoy, John Frater, Sudhin Thayyil, I G Verber, Andrew J. Pollard, Anil Gupta, Anil Kumar Gupta, Timothy Abuya, Daniel Mwanga and George M. Warimwe and has published in prestigious journals such as Immunity, Clinical Infectious Diseases and PLoS Medicine.

In The Last Decade

Mainga Hamaluba

17 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mainga Hamaluba United Kingdom 11 201 96 85 76 67 20 389
François Gasse Switzerland 7 125 0.6× 79 0.8× 64 0.8× 137 1.8× 59 0.9× 10 431
Martha H. Roper United States 9 201 1.0× 78 0.8× 144 1.7× 149 2.0× 74 1.1× 12 595
David Mercer United States 9 250 1.2× 51 0.5× 154 1.8× 69 0.9× 95 1.4× 9 531
Levent Akın Türkiye 12 114 0.6× 62 0.6× 132 1.6× 54 0.7× 37 0.6× 35 367
Jane Gidudu United States 13 252 1.3× 61 0.6× 233 2.7× 197 2.6× 97 1.4× 30 570
Lulu Bravo Philippines 11 249 1.2× 115 1.2× 162 1.9× 61 0.8× 75 1.1× 29 450
Lúcia Ferro Bricks Brazil 12 211 1.0× 196 2.0× 152 1.8× 45 0.6× 98 1.5× 53 508
А. А. Соминина Russia 9 427 2.1× 42 0.4× 208 2.4× 31 0.4× 19 0.3× 50 572
Patrick Cashman Australia 15 272 1.4× 57 0.6× 193 2.3× 238 3.1× 43 0.6× 37 481
Joyce U. Nyiro Kenya 10 407 2.0× 39 0.4× 87 1.0× 30 0.4× 137 2.0× 24 482

Countries citing papers authored by Mainga Hamaluba

Since Specialization
Citations

This map shows the geographic impact of Mainga Hamaluba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mainga Hamaluba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mainga Hamaluba more than expected).

Fields of papers citing papers by Mainga Hamaluba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mainga Hamaluba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mainga Hamaluba. The network helps show where Mainga Hamaluba may publish in the future.

Co-authorship network of co-authors of Mainga Hamaluba

This figure shows the co-authorship network connecting the top 25 collaborators of Mainga Hamaluba. A scholar is included among the top collaborators of Mainga Hamaluba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mainga Hamaluba. Mainga Hamaluba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tiffin, Nicki, Mainga Hamaluba, Collen Masimirembwa, et al.. (2026). Six ways to empower African research and development for health. 1(1). 12–15.
2.
Bejon, Philip, Ambrose Agweyu, Lynette Isabella Ochola‐Oyier, et al.. (2025). Rethinking the evidence on COVID-19 in Africa. The Lancet Infectious Diseases. 25(8). e463–e471. 1 indexed citations
3.
Bellamy, Duncan, Rodney Ogwang, Domtila Kimani, et al.. (2025). Vaccine-induced responses to R21/Matrix-M – an analysis of samples from a phase 1b age de-escalation, dose-escalation trial. Frontiers in Immunology. 16. 1620366–1620366.
4.
Maitland, Kathryn, Mainga Hamaluba, Florence Alaroker, et al.. (2025). Early weaning from oxygen therapy in African children with severe pneumonia. BMC Medicine. 23(1). 366–366.
5.
Nkumama, Irene N., Rodney Ogwang, Kennedy Mwai, et al.. (2024). Breadth of Fc-mediated effector function correlates with clinical immunity following human malaria challenge. Immunity. 57(6). 1215–1224.e6. 5 indexed citations
6.
Abouyannis, Michael, Mwanamvua Boga, Amek Nyaguara, et al.. (2023). A long-term observational study of paediatric snakebite in Kilifi County, south-east Kenya. PLoS neglected tropical diseases. 17(7). e0010987–e0010987. 8 indexed citations
7.
Mumba, Noni, Patricia Njuguna, Primus Che, et al.. (2022). Undertaking Community Engagement for a Controlled Human Malaria Infection Study in Kenya: Approaches and Lessons Learnt. Frontiers in Public Health. 10. 793913–793913. 3 indexed citations
8.
Otiende, Mark, Symon M. Kariuki, Donwilliams O. Omuoyo, et al.. (2022). Incidence of chikungunya virus infections among Kenyan children with neurological disease, 2014–2018: A cohort study. PLoS Medicine. 19(5). e1003994–e1003994. 7 indexed citations
9.
Abouyannis, Michael, Dinesh Aggarwal, David G. Lalloo, et al.. (2021). Clinical outcomes and outcome measurement tools reported in randomised controlled trials of treatment for snakebite envenoming: A systematic review. PLoS neglected tropical diseases. 15(8). e0009589–e0009589. 15 indexed citations
10.
Kapulu, Melissa C., Patricia Njuguna, Mainga Hamaluba, et al.. (2021). Safety and PCR monitoring in 161 semi-immune Kenyan adults following controlled human malaria infection. JCI Insight. 6(17). 12 indexed citations
11.
Orangi, Stacey, Jessie Pinchoff, Daniel Mwanga, et al.. (2021). Assessing the Level and Determinants of COVID-19 Vaccine Confidence in Kenya. Vaccines. 9(8). 936–936. 70 indexed citations
12.
13.
Pulickal, Anoop S., Martin Callaghan, Dominic F. Kelly, et al.. (2013). Prevalence and Genetic Analysis of Phenotypically Vi- Negative Salmonella Typhi Isolates in Children from Kathmandu, Nepal. Journal of Tropical Pediatrics. 59(4). 317–320. 10 indexed citations
14.
15.
Kelly, Dominic F., Stephen Thorson, Mainga Hamaluba, et al.. (2010). The burden of vaccine-preventable invasive bacterial infections and pneumonia in children admitted to hospital in urban Nepal. International Journal of Infectious Diseases. 15(1). e17–e23. 30 indexed citations
16.
Williams, Eleri, Stephen Thorson, Mainga Hamaluba, et al.. (2009). Hospital‐Based Surveillance of Invasive Pneumococcal Disease among Young Children in Urban Nepal. Clinical Infectious Diseases. 48(s2). S114–S122. 30 indexed citations
17.
Pace, David, Matthew D. Snape, Mainga Hamaluba, et al.. (2007). A New Combination Haemophilus influenzae Type B and Neisseria meningitidis Serogroup C-Tetanus Toxoid Conjugate Vaccine for Primary Immunization of Infants. The Pediatric Infectious Disease Journal. 26(11). 1057–1059. 21 indexed citations
18.
19.
Thayyil, Sudhin, Mohan Shenoy, Mainga Hamaluba, et al.. (2005). Is procalcitonin useful in early diagnosis of serious bacterial infections in children?. Acta Paediatrica. 94(2). 155–158. 63 indexed citations
20.
Thayyil, Sudhin, Mohan Shenoy, Mainga Hamaluba, et al.. (2005). Is procalcitonin useful in early diagnosis of serious bacterial infections in children?. Acta Paediatrica. 94(2). 155–158. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by François Gasse Breakdown of academic impact, for papers by Martha H. Roper Breakdown of academic impact, for papers by David Mercer Breakdown of academic impact, for papers by Levent Akın Breakdown of academic impact, for papers by Jane Gidudu Breakdown of academic impact, for papers by Lulu Bravo Breakdown of academic impact, for papers by Lúcia Ferro Bricks Breakdown of academic impact, for papers by А. А. Соминина Breakdown of academic impact, for papers by Patrick Cashman Breakdown of academic impact, for papers by Joyce U. Nyiro
Rankless by CCL
2026